certolizumab
ucb pharmaceuticals
['certolizumab', 'axspa']
abstract 0543 at #acr22
exploratory analysis of potential disconnect between objective inflammatory response &amp; clinical response following certolizumab pegol in axspa #spondyloarthritis
/nz 
Annals of the Rheumatic Diseases (#1 research journal in Rheumatology) & RMD Open are the official @EULAR_ORG journals. High quality, peer reviewed research.